Skip to main content

GENERAL COMMENTARY article

Front. Pharmacol., 21 July 2016
Sec. Pharmacology of Anti-Cancer Drugs
Volume 7 - 2016 | https://doi.org/10.3389/fphar.2016.00228

Expression of Concern: Discoidin Domain Receptors: Potential Actors and Targets in Cancer

This article is a commentary on:

  1. Discoidin Domain Receptors: Potential Actors and Targets in Cancer

    1. Read original article
\r\nFrontiers Editorial Office*Frontiers Editorial Office*

An expression of concern on
Discoidin Domain Receptors: Potential Actors and Targets in Cancer

by Rammal. H., Saby. C., Magnien. K., Van-Gulick. L., Garnotel, R., Buache, E., et al. (2016). Front. Pharmacol. 7:55. doi: 10.3389/fphar.2016.00055

With this notice, Frontiers states its awareness of concerns regarding a number of instances of failure to adequately cite or attribute credit appropriately within the above-referenced article. Prof. Theophile Godfraind and Prof. Olivier Feron, Chief Editors of the journal and specialty section respectively, will direct an investigation in full accordance with our procedures. The situation will be updated as soon as the investigation is complete.

UPDATE: This article has now been corrected. Please find the full correction here: https://doi.org/10.3389/fphar.2016.00346

Citation: Frontiers Editorial Office (2016) Expression of Concern: Discoidin Domain Receptors: Potential Actors and Targets in Cancer. Front. Pharmacol. 7:228. doi: 10.3389/fphar.2016.00228

Received: 14 July 2016; Accepted: 14 July 2016;
Published: 21 July 2016.

Edited and reviewed by: Théophile Godfraind, Université catholique de Louvain, Belgium

Copyright © 2016 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.